Delivery Order SPE2DB20D3505-SPE2DB24FU8C6

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a ceiling value of $8,052.90 and a firm fixed price. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to provide epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.60 firm-fixed-price delivery order is for the supply of Epinephrine 0.15 mg auto-injectors, with a completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $4,229.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of epinephrine 0.3 mg auto-injectors, a critical medical supply for military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $2,067.08 firm fixed price award is for the supply of 4,565,215,508 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen, through its Corporate Office division, has been a significant provider of...
This federal contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver epinephrine 0.3 mg auto-injector to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,593.12 and is a firm fixed price delivery order that will run through October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of epinephrine 0.15 mg auto-injectors. The contract, valued at $1,856.40, is a firm fixed-price delivery order with a completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,999.73 firm-fixed-price delivery order is for 4,565,965,417 units of epinephrine 0.15 mg auto-injectors, with a completion date of September 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,144.85 firm fixed-price delivery order is for the supply of 4566913968, which appears to be epinephrine 0.3 mg auto-injector 2s. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,089,562 units of the epinephrine 0.15 mg auto-injector medical product. The $4,346.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on July 8, 2024, with a completion date of July 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
The federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The fixed-price, firm-fixed delivery order, valued at $1,861.44, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU8C6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,748.86 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract delivers epinephrine 0.15 mg auto-injectors to support military healthcare programs. Amerisourcebergen holds a $999,999,999 IDC with the DLA, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, enabling efficient procurement of essential pharmaceutical and medical supplies for federal agencies. This award was not designated with any set-aside requirements, indicating open competition. The contract has an ultimate completion date of August 15, 2024.

Generated 2/27/25, 11:33 AM